# Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients

> **NCT00252655** · PHASE4 · UNKNOWN · sponsor: **Wayne State University** · enrollment: 40 (—)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Rapamune and Prograf

## Key facts

- **NCT ID:** NCT00252655
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2009-06
- **Target enrollment:** 40 (—)
- **Last updated:** 2007-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252655, "Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00252655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*